NioCorp Developments has secured a 10-year non-binding offtake agreement with Traxys, validating the sales channel for its Elk Creek mining project. The company targets six minerals with a unique non-open-pit mining model, focusing on rare earth elements and scandium, which offer strong revenue potential. With $419 million in cash and an $800 million EXIM debt application, NioCorp is well-positioned to fund the $1.2 billion Elk Creek capital expenditure, reducing dilution risk. Upcoming feasibility study results and the confirmed offtake deal are expected to clarify project costs and net present value, potentially triggering a market re-rating.
Rein Therapeutics completed a $57.5 million underwritten public offering by selling 57.5 million shares at $1.00 each, including the full exercise of an over-allotment option. The proceeds will fund the Phase 2 clinical trial of their drug LTI-03 for...
Streamex Corp. announced its second monthly yield distribution for GLDY, a gold-backed tokenized security, covering April 2026. The yield is generated through Streamex's institutional gold leasing program, which currently earns an annualized lease yi...
TOYO Co., Ltd announced a 177% increase in Q1 2026 revenue to $142.8 million, driven by higher solar cell and module sales. Net income rose to $28.4 million from a loss of $3.7 million in Q1 2025, with EBITDA improving significantly. The company reaf...
IREN Limited has acquired Awaken, a creative and media agency, to strengthen its brand awareness and marketing as it expands globally. Awaken, previously IREN's external marketing partner, will now operate in-house with key team members, including CE...
Sitryx Therapeutics, a clinical-stage biopharmaceutical company focused on autoimmune and inflammatory diseases, announced its management will participate in three key investor conferences in June 2026: Jefferies Global Healthcare Conference in New Y...
